Fluoropharma Medical Ownership

FPMI Stock  USD 0.0001  0.00  0.00%   
Fluoropharma Medical holds a total of 34.26 Million outstanding shares. Roughly 99.66 percent of Fluoropharma Medical outstanding shares are held by general public with 0.34 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Fluoropharma Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Fluoropharma Medical, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fluoropharma Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Fluoropharma Pink Sheet Ownership Analysis

The company recorded a loss per share of 0.08. Fluoropharma Medical had not issued any dividends in recent years. FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for Fluoropharma Medical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Fluoropharma Medical call Thomas Tulip at 973-744-1565 or check out https://www.fluoropharma.com.

Fluoropharma Medical Outstanding Bonds

Fluoropharma Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fluoropharma Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fluoropharma bonds can be classified according to their maturity, which is the date when Fluoropharma Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Fluoropharma Pink Sheet

Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.